{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:11:57Z","timestamp":1793725917790,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Device-associated infections (DAIs) are a significant cause of morbidity following living donor liver transplantation (LDLT). We aimed to assess the impact of bundled care on reducing rates of device-associated infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a before-and-after comparative study at a liver transplantation facility over a three-year period, spanning from January 2016 to December 2018. The study included a total of 57 patients who underwent LDLT. We investigated the implementation of a care bundle, which consists of multiple evidence-based procedures that are consistently performed as a unified unit. We divided our study into three phases and implemented a bundled care approach in the second phase. Rates of pneumonia related to ventilators [VAP], bloodstream infections associated with central line [CLABSI], and urinary tract infections associated with catheters [CAUTI] were assessed throughout the study period. Bacterial identification and antibiotic susceptibility testing were performed using the automated Vitek-2 system. The comparison between different phases was assessed using the chi-square test or the Fisher exact test for qualitative values and the Kruskal-Wallis H test for quantitative values with non-normal distribution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the baseline phase, the VAP rates were 73.5, the CAUTI rates were 47.2, and the CLABSI rates were 7.4 per one thousand device days (PDD). During the bundle care phase, the rates decreased to 33.3, 18.18, and 4.78. In the follow-up phase, the rates further decreased to 35.7%, 16.8%, and 2.7% PDD. The prevalence of <jats:italic>Klebsiella pneumonia<\/jats:italic> (37.5%) and Methicillin resistance <jats:italic>Staph aureus<\/jats:italic> (37.5%) in VAP were noted. The primary causative agent of CAUTI was <jats:italic>Candida albicans<\/jats:italic>, accounting for 33.3% of cases, whereas Coagulase-negative <jats:italic>Staph<\/jats:italic> was the predominant organism responsible for CLABSI, with a prevalence of 40%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrates the effectiveness of utilizing the care bundle approach to reduce DAI in LDLT, especially in low socioeconomic countries with limited resources. By implementing a comprehensive set of evidence-based interventions, healthcare systems can effectively reduce the burden of DAI, enhance infection prevention strategies and improve patient outcomes in resource-constrained settings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09525-4","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T09:03:34Z","timestamp":1720170214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bundle care approach to reduce device associated infections in post-living-donor-liver transplantation in a tertiary care hospital, Egypt"],"prefix":"10.1186","volume":"24","author":[{"given":"Mona A.","family":"Wassef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M.","family":"Ghaith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Hussien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"El-Shazly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham H. A.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"issue":"19\u201320","key":"9525_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00508-016-1046-1","volume":"128","author":"I -Graziadei","year":"2016","unstructured":"Graziadei I, Zoller H, Fickert P, Schneeberger S, Finkenstedt A, Peck-Radosavljevic M, et al. Indications for liver transplantation in adults. Wiener Klinische Wochenschrift. 2016;128(19\u201320):679\u201390. https:\/\/doi.org\/10.1007\/s00508-016-1046-1","journal-title":"Wiener Klinische Wochenschrift"},{"key":"9525_CR2","unstructured":"El-Zanaty F, Way A. Egypt demographic and health survey 2008 (Egyptian Ministry of Health, El-Zanaty and Associates and Macro International, 2009). https:\/\/dhsprogram.com\/publications\/publication-fr220-dhs-final-reports.cfm Accessed 20 January 2024."},{"key":"9525_CR3","doi-asserted-by":"publisher","first-page":"8703172","DOI":"10.1155\/2018\/8703172","volume":"2018","author":"Y -Wang","year":"2018","unstructured":"Wang Y, Gu Y, Huang F, Liu D, Zhang Z, Zhou N, et al. Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation. Mediat Inflamm. 2018;2018:8703172\u20138. https:\/\/doi.org\/10.1155\/2018\/8703172","journal-title":"Mediat Inflamm"},{"issue":"4","key":"9525_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","volume":"15","author":"J -Levitsky","year":"2017","unstructured":"Levitsky J, Goldberg D, Smith AR, Mansfield SA, Gillespie BW, Merion RM, Lok AS, Levy G, Kulik L, Abecassis M, Shaked A. Acute rejection increases risk of graft failure and death in recent liver transplant recipients. Clin Gastroenterol Hepatol. 2017;15(4):584\u2013e5932. https:\/\/doi.org\/10.1016\/j.cgh.2016.07.035","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"9525_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/antibiotics13010046","volume":"13","author":"NR -Kumar","year":"2024","unstructured":"Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-resistant sepsis: a critical healthcare challenge. Antibiotics. 2024;13(1):46. https:\/\/doi.org\/10.3390\/antibiotics13010046","journal-title":"Antibiotics"},{"issue":"1","key":"9525_CR6","doi-asserted-by":"publisher","first-page":"e13001","DOI":"10.1111\/tid.13001","volume":"21","author":"G -Pouladfar","year":"2019","unstructured":"Pouladfar G, Jafarpour Z, Malek Hosseini SA, Firoozifar M, Rasekh R, Khosravifard L. Bacterial infections in pediatric patients during early post liver transplant period: a prospective study in Iran. Transpl Infect Dis. 2019;21(1):e13001. https:\/\/doi.org\/10.1111\/tid.13001","journal-title":"Transpl Infect Dis"},{"key":"9525_CR7","doi-asserted-by":"publisher","unstructured":"Prakash SS, Rajshekar D, Cherian A, Sastry AS. Care bundle approach to reduce device-associated infections in a tertiary care teaching hospital, South India. J Lab Physicians. 2017;9(4):273\u20138. https:\/\/doi.org\/10.4103\/JLP.JLP_162_16","DOI":"10.4103\/JLP.JLP_162_16"},{"key":"9525_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/IDR.S236814","volume":"13","author":"M -Wassef","year":"2020","unstructured":"Wassef M, Mukhtar A, Nabil A, Ezzelarab M, Ghaith D. Care bundle approach to reduce surgical site infections in acute surgical intensive care unit, Cairo, Egypt. Infect Drug Resist. 2020;13:229. https:\/\/doi.org\/10.2147\/IDR.S236814","journal-title":"Infect Drug Resist"},{"issue":"5","key":"9525_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"T -Horan","year":"2008","unstructured":"Horan T, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002","journal-title":"Am J Infect Control"},{"issue":"12","key":"9525_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ajic.2016.08.007","volume":"44","author":"VD -Rosenthal","year":"2016","unstructured":"Rosenthal VD, Al-Abdely HM, El-Kholy AA, AlKhawaja SA, Leblebicioglu H, Mehta Y, et al. International nosocomial infection control consortium report, data summary of 50 countries for 2010\u20132015: device-associated module. Am J Infect Control. 2016;44(12):1495\u2013504. https:\/\/doi.org\/10.1016\/j.ajic.2016.08.007","journal-title":"Am J Infect Control"},{"issue":"3","key":"9525_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP -Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"9525_CR12","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing: 27th ed. Informational supplement M100-S27. Wayne, PA: Clinical and Laboratory Standards Institute. 2017."},{"issue":"4","key":"9525_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/s0195-6701(03)00150-6","volume":"54","author":"S -Harbarth","year":"2003","unstructured":"Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54(4):258\u201366. https:\/\/doi.org\/10.1016\/s0195-6701(03)00150-6. quiz 321.","journal-title":"J Hosp Infect"},{"issue":"2","key":"9525_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/657912","volume":"32","author":"CA -Umscheid","year":"2011","unstructured":"Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101\u201314. https:\/\/doi.org\/10.1086\/657912","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"9525_CR15","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1111\/ajt.15357","volume":"19","author":"JR -Parekh","year":"2019","unstructured":"Parekh JR, Greenstein S, Sudan DL, Grieco A, Cohen ME, Hall BL, et al. Beyond death and graft survival\u2014variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. Am J Transplant. 2019;19(7):2108\u201315. https:\/\/doi.org\/10.1111\/ajt.15357","journal-title":"Am J Transplant"},{"issue":"11","key":"9525_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1017\/ice.2018.183","volume":"39","author":"PW -Schreiber","year":"2018","unstructured":"Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP, Swissnoso. The preventable proportion of healthcare-associated infections 2005\u20132016: systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(11):1277\u201395. https:\/\/doi.org\/10.1017\/ice.2018.183","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"9525_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ajic.2018.08.006","volume":"47","author":"TA -Russell","year":"2019","unstructured":"Russell TA, Fritschel E, Do J, Donovan M, Keckeisen M, Agopian VG, et al. Minimizing central line\u2013associated bloodstream infections in a high-acuity liver transplant intensive care unit. Am J Infect Control. 2019;47(3):305\u201312. https:\/\/doi.org\/10.1016\/j.ajic.2018.08.006","journal-title":"Am J Infect Control"},{"issue":"1","key":"9525_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciu239","volume":"59","author":"K -Blot","year":"2014","unstructured":"Blot K, Bergs J, Vogelaers D, Blot S, Vandijck D. Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis. 2014;59(1):96\u2013105. https:\/\/doi.org\/10.1093\/cid\/ciu239","journal-title":"Clin Infect Dis"},{"key":"9525_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.transproceed.2014.02.022","volume":"46","author":"A -Mukhtar","year":"2014","unstructured":"Mukhtar A, Abdelaal A, Hussein M, Dabous H, Fawzy I, Obayah G, et al. Infection complications and pattern of bacterial resistance in living-donor liver transplantation: a multicenter epidemiologic study in Egypt. Transpl Proc. 2014;46:1444\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2014.02.022","journal-title":"Transpl Proc"},{"key":"9525_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/cid\/civ933]","volume":"48","author":"PG -Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;48:503\u201335. https:\/\/doi.org\/10.1093\/cid\/civ933]. [PMID: 19191635.","journal-title":"Clin Infect Dis"},{"key":"9525_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jinf.2011.12.005","volume":"64","author":"L -Zhong","year":"2012","unstructured":"Zhong L, Men TY, Li H, Peng ZH, Gu Y, Ding X, et al. Multidrug-resistant gram-negative bacterial infections after liver transplantation-spectrum and risk factors. J Infect. 2012;64:299\u2013310. https:\/\/doi.org\/10.1016\/j.jinf.2011.12.005","journal-title":"J Infect"},{"key":"9525_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1399-3062.2009.00421.x","volume":"11","author":"SH -Shi","year":"2009","unstructured":"Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, et al. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis. 2009;11:405\u201312. https:\/\/doi.org\/10.1111\/j.1399-3062.2009.00421.x","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"9525_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/lt.23682","volume":"19","author":"MP -Freire","year":"2013","unstructured":"Freire MP, Soares Oshiro IC, Bonazzi PR, Guimaraes T, Ramos Figueira ER, Bacchella T, et al. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes. Liver Transpl. 2013;19(9):1011\u20139. https:\/\/doi.org\/10.1002\/lt.23682","journal-title":"Liver Transpl"},{"issue":"20","key":"9525_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4254\/wjh.v9.i20.896","volume":"9","author":"MF -Montasser","year":"2017","unstructured":"Montasser MF, Abdelkader NA, Abdelhakam SM, Dabbous H, Montasser IF, Massoud YM, Abdelmoaty W, Saleh SA, Bahaa M, Said H, El-Meteini M. Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: a single-center study. World J Hepatol. 2017;9(20):896\u2013904. https:\/\/doi.org\/10.4254\/wjh.v9.i20.896. PMID: 28804572; PMCID: PMC5534364.","journal-title":"World J Hepatol"},{"issue":"3","key":"9525_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ajic.2019.07.019","volume":"48","author":"RH -Yousef","year":"2020","unstructured":"Yousef RH, Salem MR, Mahmoud AT. Impact of implementation of a modified World Health Organization multimodal hand hygiene strategy in a university teaching hospital. Am J Infect Control. 2020;48(3):249\u201354. https:\/\/doi.org\/10.1016\/j.ajic.2019.07.019","journal-title":"Am J Infect Control"},{"key":"9525_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.amsu.2021.01.058","volume":"62","author":"I -Al-Faouri","year":"2021","unstructured":"Al-Faouri I, Okour SH, Alakour NA, Alrabadi N. Knowledge and compliance with standard precautions among registered nurses: a cross-sectional study. Ann Med Surg (Lond). 2021;62:419\u201324. https:\/\/doi.org\/10.1016\/j.amsu.2021.01.058","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"9525_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.EPX.0000444562.71691.06","volume":"89","author":"YS -Galal","year":"2014","unstructured":"Galal YS, Labib JR, Abouelhamd WA. Impact of an infection-control program on nurses\u2019 knowledge and attitude in pediatric intensive care units at Cairo University hospitals. J Egypt Public Health Assoc. 2014;89(1):22\u20138. https:\/\/doi.org\/10.1097\/01.EPX.0000444562.71691.06","journal-title":"J Egypt Public Health Assoc"},{"key":"9525_CR28","doi-asserted-by":"publisher","first-page":"e001200","DOI":"10.1136\/bmjoq-2020-001200","volume":"10","author":"P -Gupta","year":"2021","unstructured":"Gupta P, Thomas M, Patel A, et al. Bundle approach used to achieve zero central line-associated bloodstream infections in an adult coronary intensive care unit. BMJ Open Qual. 2021;10:e001200. https:\/\/doi.org\/10.1136\/bmjoq-2020-001200","journal-title":"BMJ Open Qual"},{"key":"9525_CR29","doi-asserted-by":"publisher","unstructured":"Rosenthal VD, Yin R, Nercelles P, Rivera-Molina SE et al. International nosocomial infection control consortium (INICC) report of health care associated infections, data summary of 45 countries for 2015 to 2020, adult and pediatric units, device-associated module. Am J Infect Control. 2024;6:S0196-6553(23)00879-9. https:\/\/doi.org\/10.1016\/j.ajic.2023.12.019","DOI":"10.1016\/j.ajic.2023.12.019"},{"issue":"1","key":"9525_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/ice.2023.114","volume":"45","author":"KC -Dukes","year":"2024","unstructured":"Dukes KC, Reisinger HS, Schweizer M, Ward MA, Chapin L, Ryken TC, Perl TM, Herwaldt LA. Examining barriers to implementing a surgical-site infection bundle. Infect Control Hosp Epidemiol. 2024;45(1):13\u201320. https:\/\/doi.org\/10.1017\/ice.2023.114. Epub 2023 Jul 26. PMID: 37493031; PMCID: PMC10782202.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09525-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09525-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09525-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T09:03:40Z","timestamp":1720170220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09525-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9525"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09525-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Both The Ethical Committee of the Department and Cairo University approved the study. All patients gave their written informed consent after explaining the study\u2019s aim and importance following the declaration of Helsinki. All patient data were treated with confidentiality throughout the phases of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"674"}}